Views & Analysis To PSP or not to PSP? That is NOT the question A practical guide to planning and running an effective patient support programme.
Views & Analysis Getting a rarer perspective Benefitting from insights from focus groups with rare disease patients.
Views & Analysis Patient-centricity and long-term conditions – where next? Comprehensive guidance, education and training are vital to upskill clinicians and others in patient-centred healthcare.
Views & Analysis Time to engage: How digital expands the appeal of patient en... Digital has changed the economics of patient engagement.
Views & Analysis The continuing rise of patient-centrists (and how we can hel... Communications agencies can assist pharma in putting the patient at the heart of business.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.